Empresa Ceapro Inc. Other OTC
Acciones
CRPOF
CA1499071076
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Gilles Gagnon
CEO | Chief Executive Officer | 70 | 01/01/07 |
Director of Finance/CFO | - | 05/05/15 | |
Mitch Regnier
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/23 |
Paul Moquin
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/18 |
Chief Tech/Sci/R&D Officer | - | 01/01/10 | |
General Counsel | - | - | |
Leoni DeJoya
PRN | Corporate Officer/Principal | - | 07/01/19 |
52 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Gilles Gagnon
CEO | Chief Executive Officer | 70 | 01/01/07 |
Ulrich Kosciessa
BRD | Director/Board Member | - | 27/04/15 |
William Li
BRD | Director/Board Member | 61 | 20/11/14 |
Ronald Miller
CHM | Chairman | - | 02/03/22 |
Geneviève Foster
BRD | Director/Board Member | - | 19/04/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 78 293 177 | 76 755 900 ( 98,04 %) | 0 | 98,04 % |
Información de la empresa
![Dirección Ceapro Inc.(CRPOF)](https://cdn.zonebourse.com/static/address/72988.png)
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+34,61 % | 52,85 mil M | |
-6,66 % | 38,87 mil M | |
+34,86 % | 38,24 mil M | |
-11,12 % | 26,79 mil M | |
+12,70 % | 26,16 mil M | |
-19,53 % | 19,9 mil M | |
+38,44 % | 13,18 mil M | |
+31,23 % | 12,24 mil M | |
-3,09 % | 11,79 mil M |